Cetera Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.89M Buy
65,670
+1,407
+2% +$42.3K 0.01% 843
2023
Q4
$2.11M Sell
64,263
-3,790
-6% -$103K 0.03% 487
2023
Q3
$1.9M Buy
68,053
+182
+0.3% +$5.95K 0.03% 483
2023
Q2
$2.31M Buy
67,871
+924
+1% +$29K 0.04% 416
2023
Q1
$2.01M Sell
66,947
-510
-0.8% -$15.8K 0.03% 451
2022
Q4
$1.9M Sell
67,457
-2,015
-3% -$64K 0.03% 459
2022
Q3
$2.28M Buy
69,472
+5,930
+9% +$218K 0.06% 329
2022
Q2
$2M Buy
63,542
+21,745
+52% +$760K 0.05% 376
2022
Q1
$1.92M Buy
41,797
+5,505
+15% +$262K 0.04% 426
2021
Q4
$2.22M Sell
36,292
-36,595
-50% -$2.53M 0.05% 370
2021
Q3
$5.45M Buy
72,887
+15,664
+27% +$1.31M 0.11% 199
2021
Q2
$5.29M Sell
57,223
-3,384
-6% -$288K 0.13% 175
2021
Q1
$5.38M Buy
60,607
+21,919
+57% +$2.17M 0.15% 143
2020
Q4
$3.61M Buy
38,688
+19,394
+101% +$1.55M 0.12% 178
2020
Q3
$1.23M Buy
19,294
+15,064
+356% +$883K 0.05% 332
2020
Q2
$221K Buy
+4,230
New +$181K 0.01% 816
2019
Q2
Sell
-1,740
Closed -$57K 946
2019
Q1
$57K Buy
+1,740
New +$51.4K ﹤0.01% 956

Other funds holding ARKG

Cetera Advisors's ARKG Position: Q1 2024 in Review

Cetera Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 2.2% in Q1 2024, buying an estimated $42.3K and bringing the position to 65,670 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #843.

Cetera Advisors first reported a position in ARKG in Q1 2019 and has held it in 17 quarters since. The position peaked at $5.45M in Q3 2021. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Cetera Advisors held 65,670 shares of ARK Genomic Revolution ETF worth $1.89M as of Q1 2024.
  • Cetera Advisors bought 1,407 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $42.3K.
  • ARK Genomic Revolution ETF made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #843 holding.
  • Cetera Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 17 quarters since.
  • Cetera Advisors's ARK Genomic Revolution ETF position peaked at $5.45M in Q3 2021.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.